IQVIA Holdings Inc header image

IQVIA Holdings Inc

IQV

Equity

ISIN null / Valor 39103858

New York Stock Exchange, Inc (2026-08-06)
USD 232.43-1.53%

IQVIA Holdings Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

IQVIA Holdings Inc. is a global provider of clinical research, data and technology services to the life sciences and healthcare industries. The company operates a contract research organization (CRO) business that designs and runs clinical trials, manages sites and supports patient recruitment, alongside a business that aggregates and analyzes large healthcare datasets to generate real‑world evidence, market intelligence and outcomes research for pharmaceutical, biotech, medical device and payer clients. IQVIA also offers software and technology-enabled commercial solutions, regulatory and market-access consulting, and analytics platforms that integrate claims, prescription and electronic medical record data to support development, commercialization and post‑market activities. Headquartered in Durham, North Carolina, IQVIA was formed from the combination of Quintiles and IMS Health and operates internationally as a publicly traded company.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

31.0%1Y
7.15%3Y
-6.64%5Y

Performance

42.5%1Y
35.3%3Y
33.7%5Y

Volatility

Market cap

38258 M

Market cap (USD)

Daily traded volume (Shares)

1,265,421

Daily traded volume (Shares)

1 day high/low

198.33 / 194.63

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

BridgeBio Pharma Inc
BridgeBio Pharma Inc BridgeBio Pharma Inc Valor: 48204826
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.99%USD 82.80
Alkem Laboratories Ltd.
Alkem Laboratories Ltd. Alkem Laboratories Ltd. Valor: 30689895
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.96%INR 5,608.45
Insmed Inc
Insmed Inc Insmed Inc Valor: 12614415
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
33.86%USD 132.55
Laurus Labs Ltd.
Laurus Labs Ltd. Laurus Labs Ltd. Valor: 56464789
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.36%INR 1,836.00
Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited Alembic Pharmaceuticals Limited Valor: 11500585
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.27%INR 834.60
Narayana Hrudayalaya Ltd.
Narayana Hrudayalaya Ltd. Narayana Hrudayalaya Ltd. Valor: 30795490
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.98%INR 1,883.80
Metropolis Healthcare Ltd.
Metropolis Healthcare Ltd. Metropolis Healthcare Ltd. Valor: 11536062
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.76%INR 562.55
Cohance Lifesciences Ltd
Cohance Lifesciences Ltd Cohance Lifesciences Ltd Valor: 46346459
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.54%INR 439.85
Gland Pharma Ltd.
Gland Pharma Ltd. Gland Pharma Ltd. Valor: 56038514
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.82%INR 2,617.50
MEDICLIN AG
MEDICLIN AG MEDICLIN AG Valor: 1158721
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.31%EUR 4.22